Different Dose of Methotrexate for the Treatment of Meningeal

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

See also
Status	Clinical Trial	Phase
Completed	`NCT01713699` - Circulating Tumor Cells and Cytology in Cerebrospinal Fluid of Patients Clinically Suspected for Leptomeningeal Metastases	N/A
Recruiting	`NCT01818713` - Clinical and Pharmacological Study With 2B3-101 in Patients With Breast Cancer and Leptomeningeal Metastases	Phase 2
Recruiting	`NCT02607605` - A Prospective, Observational Trial on the Diagnostic and Prognostic of LM	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT01713699 - Circulating Tumor Cells and Cytology in Cerebrospinal Fluid of Patients Clinically Suspected for Leptomeningeal Metastases

N/A

Recruiting

NCT01818713 - Clinical and Pharmacological Study With 2B3-101 in Patients With Breast Cancer and Leptomeningeal Metastases

Phase 2

Recruiting

NCT02607605 - A Prospective, Observational Trial on the Diagnostic and Prognostic of LM

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT02590510
Study type	Interventional
Source	Hebei Medical University
Contact	Hui Bu
Phone	86-13831106903
Email	buhuimy1@163.com
Status	Not yet recruiting
Phase	Phase 4
Start date	October 2015

Different Dose of Methotrexate for the Treatment of Meningeal Carcinomatosis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms